Search

Your search keyword '"Salazar, Andres M."' showing total 105 results
Start Over Author "Salazar, Andres M." Publication Year Range Last 3 years
105 results on '"Salazar, Andres M."'

1. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy

Author

Sultan, Hussein, Takeuchi, Yoshiko, Ward, Jeffrey P., Sharma, Naveen, Liu, Tian-Tian, Sukhov, Vladimir, Firulyova, Maria, Song, Yuang, Ameh, Samuel, Brioschi, Simone, Khantakova, Darya, Arthur, Cora D., White, J. Michael, Kohlmiller, Heather, Salazar, Andres M., Burns, Robert, Costa, Helio A., Moynihan, Kelly D., Yeung, Yik Andy, Djuretic, Ivana, Schumacher, Ton N., Sheehan, Kathleen C. F., Colonna, Marco, Allison, James P., Murphy, Kenneth M., Artyomov, Maxim N., and Schreiber, Robert D.

Published
2024
Full Text
View/download PDF

2. ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease

Author

Castro, Julia T., Brito, Rory, Hojo-Souza, Natalia S., Azevedo, Bárbara, Salazar, Natalia, Ferreira, Camila P., Junqueira, Caroline, Fernandes, Ana Paula, Vasconcellos, Ronnie, Cardoso, Jamille M., Aguiar-Soares, Rodrigo D. O., Vieira, Paula M. A., Carneiro, Cláudia M., Valiate, Bruno, Toledo, Cristiane, Salazar, Andres M., Caballero, Otávia, Lannes-Vieira, Joseli, Teixeira, Santuza R., Reis, Alexandre B., and Gazzinelli, Ricardo T.

Published
2023
Full Text
View/download PDF

3. Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T-cell response in low-grade gliomas

Author

Ogino, Hirokazu, Taylor, Jennie W, Nejo, Takahide, Gibson, David, Watchmaker, Payal B, Okada, Kaori, Saijo, Atsuro, Tedesco, Meghan R, Shai, Anny, Wong, Cynthia M, Rabbitt, Jane E, Olin, Michael R, Moertel, Christopher L, Nishioka, Yasuhiko, Salazar, Andres M, Molinaro, Annette M, Phillips, Joanna J, Butowski, Nicholas A, Clarke, Jennifer L, Bush, Nancy Ann Oberheim, Hervey-Jumper, Shawn L, Theodosopoulos, Philip, Chang, Susan M, Berger, Mitchel S, and Okada, Hideho

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Research, Prevention, Vaccine Related, Cancer, Clinical Trials and Supportive Activities, Orphan Drug, Brain Cancer, Neurosciences, Immunization, Brain Disorders, Biotechnology, Rare Diseases, Evaluation of treatments and therapeutic interventions, Prevention of disease and conditions, and promotion of well-being, 3.4 Vaccines, 6.1 Pharmaceuticals, Infection, Good Health and Well Being, Adult, Aged, CD8-Positive T-Lymphocytes, Cancer Vaccines, Carboxymethylcellulose Sodium, Female, Glioma, Humans, Male, Middle Aged, Neoadjuvant Therapy, Poly I-C, Polylysine, Tumor Microenvironment, Vaccination, Brain cancer, Cancer immunotherapy, Oncology, T cells, Vaccines, Medical and Health Sciences, Biological sciences, Biomedical and clinical sciences, Health sciences
Abstract

BACKGROUNDLong-term prognosis of WHO grade II low-grade gliomas (LGGs) is poor, with a high risk of recurrence and malignant transformation into high-grade gliomas. Given the relatively intact immune system of patients with LGGs and the slow tumor growth rate, vaccines are an attractive treatment strategy.METHODSWe conducted a pilot study to evaluate the safety and immunological effects of vaccination with GBM6-AD, lysate of an allogeneic glioblastoma stem cell line, with poly-ICLC in patients with LGGs. Patients were randomized to receive the vaccines before surgery (arm 1) or not (arm 2) and all patients received adjuvant vaccines. Coprimary outcomes were to evaluate safety and immune response in the tumor.RESULTSA total of 17 eligible patients were enrolled - 9 in arm 1 and 8 in arm 2. This regimen was well tolerated with no regimen-limiting toxicity. Neoadjuvant vaccination induced upregulation of type-1 cytokines and chemokines and increased activated CD8+ T cells in peripheral blood. Single-cell RNA/T cell receptor sequencing detected CD8+ T cell clones that expanded with effector phenotype and migrated into the tumor microenvironment (TME) in response to neoadjuvant vaccination. Mass cytometric analyses detected increased tissue resident-like CD8+ T cells with effector memory phenotype in the TME after the neoadjuvant vaccination.CONCLUSIONThe regimen induced effector CD8+ T cell response in peripheral blood and enabled vaccine-reactive CD8+ T cells to migrate into the TME. Further refinements of the regimen may have to be integrated into future strategies.TRIAL REGISTRATIONClinicalTrials.gov NCT02549833.FUNDINGNIH (1R35NS105068, 1R21CA233856), Dabbiere Foundation, Parker Institute for Cancer Immunotherapy, and Daiichi Sankyo Foundation of Life Science.

Published
2022

5. A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.

Author

Saijo, Atsuro, Ogino, Hirokazu, Butowski, Nicholas A, Tedesco, Meghan R, Gibson, David, Watchmaker, Payal B, Okada, Kaori, Wang, Albert S, Shai, Anny, Salazar, Andres M, Molinaro, Annette M, Rabbitt, Jane E, Shahin, Maryam, Perry, Arie, Clarke, Jennifer L, Taylor, Jennie W, Daras, Mariza, Bush, Nancy Ann Oberheim, Hervey-Jumper, Shawn L, and Phillips, Joanna J

Published
2024
Full Text
View/download PDF

6. A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas

Author

Saijo, Atsuro, primary, Ogino, Hirokazu, additional, Butowski, Nicholas A, additional, Tedesco, Meghan R, additional, Gibson, David, additional, Watchmaker, Payal B, additional, Okada, Kaori, additional, Wang, Albert S, additional, Shai, Anny, additional, Salazar, Andres M, additional, Molinaro, Annette M, additional, Rabbitt, Jane E, additional, Shahin, Maryam, additional, Perry, Arie, additional, Clarke, Jennifer L, additional, Taylor, Jennie W, additional, Daras, Mariza, additional, Oberheim Bush, Nancy Ann, additional, Hervey-Jumper, Shawn L, additional, Phillips, Joanna J, additional, Chang, Susan M, additional, Hilf, Norbert, additional, Mayer-Mokler, Andrea, additional, Keler, Tibor, additional, Berger, Mitchel S, additional, and Okada, Hideho, additional

Published
2023
Full Text
View/download PDF

9. Supplementary Figure Legend from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

12. Data from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Fig 3 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Fig 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Author

Pavlick, Anna, primary, Blazquez, Ana B., primary, Meseck, Marcia, primary, Lattanzi, Michael, primary, Ott, Patrick A., primary, Marron, Thomas U., primary, Holman, Rose Marie, primary, Mandeli, John, primary, Salazar, Andres M., primary, McClain, Christopher B., primary, Gimenez, Gustavo, primary, Balan, Sreekumar, primary, Gnjatic, Sacha, primary, Sabado, Rachel Lubong, primary, and Bhardwaj, Nina, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 2 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure 6 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 5 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Author

Okada, Hideho, primary, Butterfield, Lisa H., primary, Hamilton, Ronald L., primary, Hoji, Aki, primary, Sakaki, Masashi, primary, Ahn, Brian J., primary, Kohanbash, Gary, primary, Drappatz, Jan, primary, Engh, Johnathan, primary, Amankulor, Nduka, primary, Lively, Mark O., primary, Chan, Michael D., primary, Salazar, Andres M., primary, Shaw, Edward G., primary, Potter, Douglas M., primary, and Lieberman, Frank S., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 2 from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 1 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 2 from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure Legend from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Table 1 from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 2 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 3 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure Legends from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure Legend from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 4 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Author

Murphy, Katherine A., primary, Lechner, Melissa G., primary, Popescu, Flavia E., primary, Bedi, Jessica, primary, Decker, Stacy A., primary, Hu, Peisheng, primary, Erickson, Jami R., primary, O'Sullivan, M. Gerard, primary, Swier, Lauryn, primary, Salazar, Andres M., primary, Olin, Michael R., primary, Epstein, Alan L., primary, and Ohlfest, John R., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 3 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Author

Rapoport, Aaron P., primary, Aqui, Nicole A., primary, Stadtmauer, Edward A., primary, Vogl, Dan T., primary, Xu, Yin Yan, primary, Kalos, Michael, primary, Cai, Ling, primary, Fang, Hong-Bin, primary, Weiss, Brendan M., primary, Badros, Ashraf, primary, Yanovich, Saul, primary, Akpek, Gorgun, primary, Tsao, Patricia, primary, Cross, Alan, primary, Mann, Dean, primary, Philip, Sunita, primary, Kerr, Naseem, primary, Brennan, Andrea, primary, Zheng, Zhaohui, primary, Ruehle, Kathleen, primary, Milliron, Todd, primary, Strome, Scott E., primary, Salazar, Andres M., primary, Levine, Bruce L., primary, and June, Carl H., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 3 from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Author

Sabbatini, Paul, primary, Tsuji, Takemasa, primary, Ferran, Luis, primary, Ritter, Erika, primary, Sedrak, Christine, primary, Tuballes, Kevin, primary, Jungbluth, Achim A., primary, Ritter, Gerd, primary, Aghajanian, Carol, primary, Bell-McGuinn, Katherine, primary, Hensley, Martee L., primary, Konner, Jason, primary, Tew, William, primary, Spriggs, David R., primary, Hoffman, Eric W., primary, Venhaus, Ralph, primary, Pan, Linda, primary, Salazar, Andres M., primary, Diefenbach, Catherine Magid, primary, Old, Lloyd J., primary, and Gnjatic, Sacha, primary

Published
2023
Full Text
View/download PDF

40. Data from Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell–Mediated Antitumor Immunity

Author

Derouazi, Madiha, primary, Di Berardino-Besson, Wilma, primary, Belnoue, Elodie, primary, Hoepner, Sabine, primary, Walther, Romy, primary, Benkhoucha, Mahdia, primary, Teta, Patrick, primary, Dufour, Yannick, primary, Yacoub Maroun, Céline, primary, Salazar, Andres M., primary, Martinvalet, Denis, primary, Dietrich, Pierre-Yves, primary, and Walker, Paul R., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure Legends from Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell–Mediated Antitumor Immunity

Author

Derouazi, Madiha, primary, Di Berardino-Besson, Wilma, primary, Belnoue, Elodie, primary, Hoepner, Sabine, primary, Walther, Romy, primary, Benkhoucha, Mahdia, primary, Teta, Patrick, primary, Dufour, Yannick, primary, Yacoub Maroun, Céline, primary, Salazar, Andres M., primary, Martinvalet, Denis, primary, Dietrich, Pierre-Yves, primary, and Walker, Paul R., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figures S1-S7 from Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell–Mediated Antitumor Immunity

Author

Derouazi, Madiha, primary, Di Berardino-Besson, Wilma, primary, Belnoue, Elodie, primary, Hoepner, Sabine, primary, Walther, Romy, primary, Benkhoucha, Mahdia, primary, Teta, Patrick, primary, Dufour, Yannick, primary, Yacoub Maroun, Céline, primary, Salazar, Andres M., primary, Martinvalet, Denis, primary, Dietrich, Pierre-Yves, primary, and Walker, Paul R., primary

Published
2023
Full Text
View/download PDF

47. Abstract PR002: A pilot study of a MUC1 vaccine in current and former smokers at high risk for lung cancer

Author

Finn, Olivera J., primary, Ward, Julie, additional, Krpata, Tami, additional, Fatis, Samantha, additional, McKolanis, John, additional, Xue, Jia, additional, Beatty, Pamela, additional, Jacqueline, Camille, additional, Kaufman, Sharon, additional, Akerley, Colleen, additional, Felt, April, additional, Fursa, Karrie, additional, Holland, Anne, additional, Ambulay, Liz S., additional, Foster, Nathan, additional, McMurray, Ryan, additional, Strand, Carrie, additional, Salazar, Andres M., additional, Bengtson, Lisa, additional, Szabo, Eva, additional, Limburg, Paul, additional, Wojtowicz, Malgorzata, additional, Midthun, David E., additional, and Pennathur, Arjun, additional

Published
2023
Full Text
View/download PDF

48. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma

Author

Mueller, Sabine, primary, Taitt, Jared M., additional, Villanueva-Meyer, Javier E., additional, Bonner, Erin R., additional, Nejo, Takahide, additional, Lulla, Rishi R., additional, Goldman, Stewart, additional, Banerjee, Anu, additional, Chi, Susan N., additional, Whipple, Nicholas S., additional, Crawford, John R., additional, Gauvain, Karen, additional, Nazemi, Kellie J., additional, Watchmaker, Payal B., additional, Almeida, Neil D., additional, Okada, Kaori, additional, Salazar, Andres M., additional, Gilbert, Ryan D., additional, Nazarian, Javad, additional, Molinaro, Annette M., additional, Butterfield, Lisa H., additional, Prados, Michael D., additional, and Okada, Hideho, additional

Published
2022
Full Text
View/download PDF

49. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma

Author

Mueller, Sabine, Taitt, Jared M, Villanueva-Meyer, Javier E, Bonner, Erin R, Nejo, Takahide, Lulla, Rishi R, Goldman, Stewart, Banerjee, Anu, Chi, Susan N, Whipple, Nicholas S, Crawford, John R, Gauvain, Karen, Nazemi, Kellie J, Watchmaker, Payal B, Almeida, Neil D, Okada, Kaori, Salazar, Andres M, Gilbert, Ryan D, Nazarian, Javad, Molinaro, Annette M, Butterfield, Lisa H, Prados, Michael D, Okada, Hideho, Mueller, Sabine, Taitt, Jared M, Villanueva-Meyer, Javier E, Bonner, Erin R, Nejo, Takahide, Lulla, Rishi R, Goldman, Stewart, Banerjee, Anu, Chi, Susan N, Whipple, Nicholas S, Crawford, John R, Gauvain, Karen, Nazemi, Kellie J, Watchmaker, Payal B, Almeida, Neil D, Okada, Kaori, Salazar, Andres M, Gilbert, Ryan D, Nazarian, Javad, Molinaro, Annette M, Butterfield, Lisa H, Prados, Michael D, and Okada, Hideho

Published
2022

50. Correction for Elsayed et al., “Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines”

Author

Elsayed, Hassan, primary, Nabi, Ghulam, additional, McKinstry, William J., additional, Khoo, Keith K., additional, Mak, Johnson, additional, Salazar, Andres M., additional, Tenbusch, Matthias, additional, Temchura, Vladimir, additional, and Überla, Klaus, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results